{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_11988", "batch_size": 217, "batch_pos": 91, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 2, "answer": "no", "rationale": "The segment describes securing vaccine doses ('secures up to 665,000 doses', 'includes an option for a further 40 million vaccines') using factual language.", "method": "llm_batch", "batch_id": "batch_2_13932", "batch_size": 182, "batch_pos": 61, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 3, "answer": "no", "rationale": "The segment uses a verb ('secures') with scale, but it is not a moderate verb describing impact.", "method": "llm_batch", "batch_id": "batch_3_17256", "batch_size": 260, "batch_pos": 253, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_11536", "batch_size": 260, "batch_pos": 235, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 5, "answer": "no", "rationale": "Reports deal details.", "method": "llm_batch", "batch_id": "batch_5_14220", "batch_size": 260, "batch_pos": 233, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 6, "answer": "no", "rationale": "No minimiser or scale contrast found.", "method": "llm_batch", "batch_id": "batch_6_13372", "batch_size": 260, "batch_pos": 193, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation cue.", "method": "llm_batch", "batch_id": "batch_7_10384", "batch_size": 260, "batch_pos": 180, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 8, "answer": "yes", "rationale": "Describes securing doses and options ('secures up to 665,000 doses', 'includes an option for a further 40 million vaccines').", "method": "llm_batch", "batch_id": "batch_8_12928", "batch_size": 110, "batch_pos": 10, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
